The ANKRD11 gene (Ankyrin Repeat Domain-Containing Protein 11) is implicated in neurodevelopment and associated with autism spectrum disorder and KBG syndrome. ANKRD11 plays a critical role in regulating gene expression during brain development by interacting with chromatin and modifying histones, which affects the transcription of multiple genes involved in neuronal function and development.
Mutations in ANKRD11 can disrupt these regulatory processes, leading to abnormalities in brain structure and connectivity. This disruption contributes to the phenotypic features observed in individuals with autism spectrum disorder, including impaired social interactions, communication difficulties, and repetitive behaviors. Additionally, ANKRD11 influences the proliferation and differentiation of neurons, essential for proper brain formation and function.

The ARID1B gene (AT-rich interactive domain-containing protein 1B) is crucial for neurodevelopment and is associated with autism spectrum disorder and Coffin-Siris syndrome. ARID1B encodes a subunit of the SWI/SNF chromatin remodeling complex, which regulates the accessibility of DNA to transcription factors and, consequently, gene expression.
Mutations in ARID1B disrupt chromatin remodeling, leading to altered transcription of genes vital for brain development and function. This disruption affects neuronal differentiation, migration, and synapse formation, processes essential for proper neural connectivity and cognitive function. As a result, individuals with ARID1B mutations often exhibit features of autism spectrum disorder, such as impaired social interactions, communication challenges, and repetitive behaviors.

The ASXL3 gene (Additional Sex Combs-Like 3) is involved in chromatin modification and gene regulation, playing a significant role in neurodevelopment. Mutations in ASXL3 are associated with Bainbridge-Ropers syndrome, which often includes autism spectrum disorder features.
ASXL3 encodes a protein that interacts with polycomb group proteins, contributing to the regulation of gene expression by modifying chromatin structure. This regulation is crucial for proper neuronal development, including processes such as cell differentiation, growth, and synaptic formation.
Mutations in ASXL3 can disrupt these regulatory mechanisms, leading to abnormal brain development and function. Consequently, individuals with ASXL3 mutations often exhibit neurodevelopmental disorders characterized by intellectual disability, impaired social interactions, communication challenges, and repetitive behaviors, which are core features of autism spectrum disorder.

The ACTL6B gene (Actin-Like 6B) is critical for neurodevelopment and has been associated with autism spectrum disorder and intellectual disabilities. ACTL6B encodes a component of the BAF (BRG1/brm-associated factor) chromatin remodeling complex, which regulates the accessibility of DNA to transcription factors, thereby influencing gene expression.
Mutations in ACTL6B disrupt the function of the BAF complex, leading to altered transcription of genes essential for brain development and neuronal function. This disruption affects various neurodevelopmental processes, including neuronal differentiation, migration, and synapse formation, which are crucial for proper brain connectivity and cognitive function.
Individuals with ACTL6B mutations often exhibit neurodevelopmental disorders with symptoms that include intellectual disability, motor deficits, impaired social interactions, communication challenges, and repetitive behaviors, which are characteristic of autism spectrum disorder.

The AHDC1 gene (AT-Hook DNA Binding Motif Containing 1) plays a crucial role in neurodevelopment and is associated with Xia-Gibbs syndrome, a condition that often includes autism spectrum disorder features. AHDC1 encodes a protein involved in DNA binding and gene regulation, influencing the expression of genes essential for brain development and function.
Mutations in AHDC1 can disrupt these regulatory processes, leading to abnormalities in brain structure and connectivity. This disruption contributes to the clinical manifestations observed in individuals with AHDC1 mutations, such as intellectual disability, developmental delays, motor deficits, impaired social interactions, communication challenges, and repetitive behaviors, which are characteristic of autism spectrum disorder.

The BAF190 gene, also known as SMARCA4, encodes a core subunit of the SWI/SNF (BAF) chromatin remodeling complex. This complex plays a vital role in regulating gene expression by modifying chromatin structure, which is crucial for various cellular processes, including neurodevelopment.
Mutations in BAF190 (SMARCA4) can lead to significant disruptions in chromatin remodeling, resulting in altered gene expression patterns essential for brain development and neuronal function. These disruptions can impair processes such as neuronal differentiation, migration, and synapse formation, which are critical for proper brain connectivity and cognitive function.
Individuals with BAF190 (SMARCA4) mutations often exhibit neurodevelopmental disorders that include autism spectrum disorder features. These features can encompass intellectual disability, developmental delays, impaired social interactions, communication challenges, and repetitive behaviors.

The ANK2 gene (Ankyrin 2), also known as ankyrin-B, encodes a protein critical for the proper functioning of the nervous system. ANK2 is involved in organizing and stabilizing the structure of the cell membrane, particularly in neurons, by anchoring integral membrane proteins to the cytoskeleton.
Mutations in ANK2 can disrupt the structural integrity and signaling pathways within neurons, leading to abnormalities in brain development and function. These disruptions can impair neuronal connectivity and synaptic transmission, which are essential for cognitive processes and behavioral regulation.
Individuals with ANK2 mutations often present with neurodevelopmental disorders, including autism spectrum disorder. Clinical manifestations may include intellectual disability, impaired social interactions, communication difficulties, and repetitive behaviors. Additionally, ANK2 mutations can lead to a range of other neurological and cardiac issues, reflecting the gene's broad role in cellular function.

The ASH1L gene (ASH1-like histone lysine methyltransferase) plays a critical role in epigenetic regulation of gene expression, which is essential for proper neurodevelopment. ASH1L encodes a protein that functions as a histone methyltransferase, specifically modifying histones to regulate chromatin structure and gene transcription.
Mutations in ASH1L can disrupt its role in histone modification, leading to aberrant gene expression patterns that affect brain development and function. These disruptions can impair neuronal differentiation, migration, and synaptic formation, which are crucial for cognitive processes and behavioral regulation.
Individuals with ASH1L mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with ASH1L mutations may include intellectual disability, impaired social interactions, communication difficulties, and repetitive behaviors. Additionally, these individuals may present with other developmental delays and neurological abnormalities.

The ASH1L gene (ASH1-like histone lysine methyltransferase) plays a critical role in epigenetic regulation of gene expression, which is essential for proper neurodevelopment. ASH1L encodes a protein that functions as a histone methyltransferase, specifically modifying histones to regulate chromatin structure and gene transcription.
Mutations in ASH1L can disrupt its role in histone modification, leading to aberrant gene expression patterns that affect brain development and function. These disruptions can impair neuronal differentiation, migration, and synaptic formation, which are crucial for cognitive processes and behavioral regulation.
Individuals with ASH1L mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with ASH1L mutations may include intellectual disability, impaired social interactions, communication difficulties, and repetitive behaviors. Additionally, these individuals may present with other developmental delays and neurological abnormalities.

The BCL11A gene (B-Cell CLL/Lymphoma 11A) plays a significant role in the regulation of gene expression during neurodevelopment. BCL11A encodes a zinc finger protein that acts as a transcriptional regulator, influencing the expression of genes involved in brain development, neuronal differentiation, and synaptic plasticity.
Mutations in BCL11A can lead to disruptions in these regulatory processes, resulting in altered brain development and function. These disruptions can affect neuronal connectivity and synaptic formation, which are crucial for cognitive function and behavioral regulation.
Individuals with BCL11A mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical manifestations of BCL11A mutations can include intellectual disability, developmental delays, impaired social interactions, communication challenges, and repetitive behaviors. Additionally, BCL11A mutations may be associated with hematological abnormalities, given its role in hematopoiesis.

The CHD2 gene (Chromodomain Helicase DNA Binding Protein 2) plays a crucial role in chromatin remodeling and gene expression regulation, which are vital for proper neurodevelopment. CHD2 encodes a protein that functions as part of the chromatin remodeling complex, influencing the structure of chromatin and thereby regulating access to DNA for transcription.

Mutations in CHD2 can disrupt these chromatin remodeling processes, leading to aberrant gene expression patterns that affect brain development and neuronal function. These disruptions can impair processes such as neuronal differentiation, migration, and synaptic formation, which are essential for cognitive and behavioral regulation.
Individuals with CHD2 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with CHD2 mutations may include intellectual disability, developmental delays, epilepsy, impaired social interactions, communication difficulties, and repetitive behaviors.

The CHD8 gene (Chromodomain Helicase DNA Binding Protein 8) is crucial for chromatin remodeling and gene expression regulation, which are essential for neurodevelopment. CHD8 encodes a protein that functions as part of the chromatin remodeling complex, influencing chromatin structure and regulating the accessibility of DNA for transcription.
Mutations or deletions in CHD8 can disrupt chromatin remodeling, leading to abnormal gene expression patterns that impact brain development and neuronal function. These disruptions can affect processes such as neuronal differentiation, migration, and synaptic formation, which are vital for cognitive functions and behavioral regulation.
Individuals with CHD8 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features of CHD8 mutations include intellectual disability, developmental delays, macrocephaly, impaired social interactions, communication challenges, and repetitive behaviors. Additionally, CHD8 mutations have been linked to gastrointestinal issues and sleep disturbances.

The CTNNB1 gene (Catenin Beta 1) encodes β-catenin, a multifunctional protein involved in the Wnt signaling pathway and cell adhesion processes. This gene plays a critical role in neurodevelopment, influencing cell proliferation, differentiation, and migration.
Mutations in CTNNB1 can disrupt these signaling and cell adhesion processes, leading to abnormalities in brain development and function. These disruptions can impair neuronal connectivity and synaptic formation, which are essential for cognitive functions and behavioral regulation.
Individuals with CTNNB1 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with CTNNB1 mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features can include motor deficits, microcephaly, and distinctive facial features.

The CUL3 gene (Cullin 3) is integral to the ubiquitin-proteasome system, which regulates protein degradation and turnover. CUL3 encodes a protein that functions as a scaffold in E3 ubiquitin ligase complexes, facilitating the ubiquitination and subsequent degradation of target proteins. This process is crucial for maintaining cellular homeostasis and regulating various cellular functions, including neurodevelopment.
Mutations in CUL3 can disrupt the ubiquitin-proteasome system, leading to the accumulation of misfolded or damaged proteins and altered cellular signaling pathways. These disruptions can impair neurodevelopmental processes such as neuronal differentiation, migration, and synaptic plasticity, which are essential for proper brain function and cognitive development.
Individuals with CUL3 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with CUL3 mutations may include intellectual disability, developmental delays, impaired social interactions, communication challenges, and repetitive behaviors. Additionally, CUL3 mutations may be associated with other neurological and physiological abnormalities due to its broad role in cellular regulation.

The DYRK1A gene (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A) is crucial for brain development and function. DYRK1A encodes a protein kinase involved in various cellular processes, including cell proliferation, differentiation, and apoptosis. It also plays a role in neuronal development, synaptic plasticity, and cognitive function. Mutations in DYRK1A can disrupt its kinase activity, leading to abnormalities in brain development and function. These disruptions can impair neuronal differentiation, migration, and synapse formation, which are essential for cognitive processes and behavioral regulation. Individuals with DYRK1A mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with DYRK1A mutations may include intellectual disability, developmental delays, microcephaly, motor deficits, impaired social interactions, communication difficulties, and repetitive behaviors. Additionally, individuals may present with distinct facial features and other congenital anomalies.

The FOXP1 gene (Forkhead Box P1) plays a critical role in brain development and function. FOXP1 encodes a transcription factor that regulates the expression of various genes involved in neurodevelopmental processes, including neuronal differentiation, migration, and synaptic plasticity.
Mutations in FOXP1 can disrupt its regulatory functions, leading to abnormalities in brain development and neuronal connectivity. These disruptions can impair cognitive functions and behavioral regulation, contributing to the clinical manifestations observed in individuals with FOXP1 mutations.
Individuals with FOXP1 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with FOXP1 mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additionally, individuals may present with language impairments and motor deficits.

The GRIN2B gene (Glutamate Ionotropic Receptor NMDA Type Subunit 2B) is essential for proper brain development and function. GRIN2B encodes a subunit of the NMDA receptor, a critical receptor for glutamate, which is the primary excitatory neurotransmitter in the brain. The NMDA receptor plays a key role in synaptic plasticity, learning, and memory.
Mutations in GRIN2B can disrupt NMDA receptor function, leading to altered synaptic transmission and impaired neural connectivity. These disruptions can affect cognitive processes and behavioral regulation, contributing to the clinical manifestations observed in individuals with GRIN2B mutations.
Individuals with GRIN2B mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with GRIN2B mutations may include intellectual disability, developmental delays, epilepsy, impaired social interactions, communication difficulties, and repetitive behaviors. Additionally, individuals may present with motor deficits and other neurological symptoms.

The KDM6B gene (Lysine Demethylase 6B), also known as JMJD3, is involved in the regulation of gene expression through its role in epigenetic modifications. KDM6B encodes a histone demethylase enzyme that specifically demethylates trimethylated lysine 27 on histone H3 (H3K27me3), a key marker of transcriptional repression. By removing this repressive mark, KDM6B activates the expression of genes essential for neurodevelopment.
Mutations in KDM6B can disrupt its demethylase activity, leading to aberrant gene expression and altered chromatin structure. These disruptions can impair neurodevelopmental processes such as neuronal differentiation, migration, and synapse formation, which are crucial for cognitive function and behavioral regulation.
Individuals with KDM6B mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with KDM6B mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include facial dysmorphisms and growth abnormalities.

The KMT2E gene (Lysine Methyltransferase 2E), also known as MLL5, plays a critical role in the regulation of gene expression through its involvement in epigenetic modifications. KMT2E encodes a protein that functions as a histone methyltransferase, specifically adding methyl groups to lysine residues on histone proteins, which impacts chromatin structure and gene transcription.
Mutations in KMT2E can disrupt its methyltransferase activity, leading to abnormal gene expression and altered chromatin structure. These disruptions can impair neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are essential for proper brain function and cognitive development.
Individuals with KMT2E mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with KMT2E mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additionally, individuals may present with motor deficits and other neurological symptoms.

The MBD5 gene (Methyl-CpG Binding Domain Protein 5) plays a critical role in regulating gene expression, particularly through its involvement in epigenetic modifications. MBD5 encodes a protein that binds to methylated DNA, influencing chromatin structure and gene transcription. This regulatory function is crucial for proper neurodevelopment and brain function.
Mutations in MBD5 can disrupt its ability to modulate gene expression, leading to abnormal chromatin structure and altered transcriptional activity. These disruptions can impair neurodevelopmental processes such as neuronal differentiation, migration, and synapse formation, which are essential for cognitive function and behavioral regulation.
Individuals with MBD5 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with MBD5 mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include motor deficits, seizures, and distinctive facial features.

The MED13L gene (Mediator Complex Subunit 13 Like) plays a crucial role in the regulation of gene expression by being a part of the mediator complex, which bridges transcription factors and RNA polymerase II, facilitating the transcription of genes. This regulatory function is essential for proper neurodevelopment and various cellular processes.
Mutations in MED13L can disrupt the function of the mediator complex, leading to aberrant gene expression. These disruptions can affect neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are critical for cognitive function and behavioral regulation.
Individuals with MED13L mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with MED13L mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include congenital heart defects, motor deficits, and distinctive facial features.

The REST gene (RE1-Silencing Transcription factor), also known as NRSF (Neuron-Restrictive Silencer Factor), plays a critical role in regulating gene expression, particularly in neuronal cells. REST encodes a transcription factor that represses the expression of neuronal genes in non-neuronal tissues, ensuring that neuronal-specific genes are expressed only in the appropriate context.
Mutations in REST can disrupt its repressive functions, leading to inappropriate expression of neuronal genes and altered chromatin structure. These disruptions can impair neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are crucial for proper brain function and cognitive development.
Individuals with REST mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with REST mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additionally, individuals may present with epilepsy and other neurological symptoms.

The SCN2A gene (Sodium Voltage-Gated Channel Alpha Subunit 2) is crucial for the proper functioning of the nervous system. SCN2A encodes a protein that forms part of the voltage-gated sodium channels, which are essential for the initiation and propagation of action potentials in neurons. These channels play a key role in neuronal excitability and signaling.
Mutations in SCN2A can disrupt the function of sodium channels, leading to altered neuronal excitability and impaired neural communication. These disruptions can affect neurodevelopmental processes and contribute to various neurological disorders.
Individuals with SCN2A mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with SCN2A mutations may include intellectual disability, developmental delays, epilepsy, impaired social interactions, communication difficulties, and repetitive behaviors. The severity of symptoms can vary widely, depending on the nature of the mutation and its impact on sodium channel function.

The SMARCC2 gene (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily C, Member 2), also known as BAF170, encodes a core component of the SWI/SNF chromatin remodeling complex. This complex plays a crucial role in regulating gene expression by modifying chromatin structure, which is essential for various cellular processes, including neurodevelopment.
Mutations in SMARCC2 can disrupt the function of the SWI/SNF complex, leading to altered gene expression and chromatin structure. These disruptions can impair neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are vital for cognitive functions and behavioral regulation.
Individuals with SMARCC2 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with SMARCC2 mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include growth abnormalities and other congenital anomalies.

The SYNGAP1 gene (Synaptic Ras GTPase Activating Protein 1) is crucial for proper synaptic function and neurodevelopment. SYNGAP1 encodes a protein that plays a key role in regulating synaptic plasticity, which is essential for learning, memory, and cognitive function. It is involved in signaling pathways that modulate the strength and formation of synapses in the brain.
Mutations in SYNGAP1 can disrupt these signaling pathways, leading to impaired synaptic function and altered neuronal connectivity. These disruptions can significantly impact neurodevelopmental processes, contributing to various neurological disorders.
Individuals with SYNGAP1 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with SYNGAP1 mutations may include intellectual disability, developmental delays, epilepsy, impaired social interactions, communication difficulties, and repetitive behaviors. The severity of symptoms can vary widely depending on the nature of the mutation and its effect on synaptic function.

The HIVEP2 gene (Human Immunodeficiency Virus Type I Enhancer Binding Protein 2), also known as ZAS2, encodes a transcription factor involved in the regulation of gene expression. HIVEP2 influences various cellular processes, including immune responses and neurodevelopment, by binding to specific DNA sequences and modulating the transcription of target genes.
Mutations in HIVEP2 can disrupt its regulatory functions, leading to altered gene expression and impaired cellular processes. In the context of neurodevelopment, such disruptions can affect neuronal differentiation, migration, and synaptic formation, which are crucial for proper brain function and cognitive development.
Individuals with HIVEP2 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with HIVEP2 mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additionally, individuals may present with motor deficits and other neurological symptoms.

The HNRNPH2 gene (Heterogeneous Nuclear Ribonucleoprotein H2) plays a critical role in the regulation of RNA processing, including splicing, transport, and stability. HNRNPH2 encodes a protein that is part of the heterogeneous nuclear ribonucleoproteins (hnRNPs) family, which are involved in the formation of mRNA and its processing.
Mutations in HNRNPH2 can disrupt its role in RNA processing, leading to the production of aberrant mRNAs and altered gene expression. These disruptions can significantly affect neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are essential for cognitive function and behavioral regulation.
Individuals with HNRNPH2 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with HNRNPH2 mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include seizures, motor deficits, and distinctive facial features.

The PPP2R5D gene (Protein Phosphatase 2 Regulatory Subunit B' Delta) encodes a regulatory subunit of protein phosphatase 2A (PP2A), a major serine/threonine phosphatase that plays a crucial role in various cellular processes, including cell growth, division, and signal transduction. PP2A is essential for proper neurodevelopment and brain function.
Mutations in PPP2R5D can disrupt the function of PP2A, leading to aberrant cellular signaling and altered regulation of key pathways involved in neurodevelopment. These disruptions can impair processes such as neuronal differentiation, migration, and synaptic plasticity, which are vital for cognitive function and behavioral regulation.
Individuals with PPP2R5D mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with PPP2R5D mutations may include intellectual disability, developmental delays, macrocephaly, hypotonia, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include seizures and other neurological symptoms.

The CHAMP1 gene (Chromosome Alignment Maintaining Phosphoprotein 1) plays a significant role in chromosomal segregation during cell division and proper neurodevelopment. CHAMP1 encodes a protein involved in the regulation of mitotic spindle assembly and chromosome alignment, ensuring accurate cell division.
Mutations in CHAMP1 can disrupt these critical processes, leading to chromosomal instability and altered cellular function. These disruptions can significantly affect neurodevelopmental processes, such as neuronal differentiation, migration, and synaptic formation, which are essential for cognitive function and behavioral regulation.
Individuals with CHAMP1 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with CHAMP1 mutations may include intellectual disability, developmental delays, hypotonia, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include distinctive facial features and other congenital anomalies.

The CSNK2A1 gene (Casein Kinase II Alpha 1) encodes the alpha subunit of casein kinase II (CK2), a serine/threonine-specific protein kinase involved in regulating various cellular processes, including cell cycle control, apoptosis, and DNA repair. CK2 is also essential for neurodevelopment and synaptic function.
Mutations in CSNK2A1 can disrupt CK2's kinase activity, leading to aberrant phosphorylation of key proteins involved in neuronal development and function. These disruptions can impair neurodevelopmental processes such as neuronal differentiation, migration, and synaptic plasticity, which are crucial for cognitive function and behavioral regulation.
Individuals with CSNK2A1 mutations often exhibit neurodevelopmental disorders, including Autism Spectrum Disorder (ASD). Clinical features associated with CSNK2A1 mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include motor deficits, seizures, and other neurological symptoms.

The CTBP1 gene (C-terminal Binding Protein 1) encodes a transcriptional co-repressor involved in various cellular processes, including development, differentiation, and apoptosis. CTBP1 interacts with various transcription factors to regulate the expression of genes essential for neurodevelopment.
Mutations in CTBP1 can disrupt its co-repressor functions, leading to altered gene expression and dysregulation of key developmental pathways. These disruptions can impair neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are crucial for cognitive function and behavioral regulation.
Individuals with CTBP1 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with CTBP1 mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include motor deficits, hypotonia, and other neurological symptoms.

The DDX3X gene (DEAD-Box Helicase 3, X-Linked) encodes an RNA helicase that is involved in various aspects of RNA metabolism, including transcription, splicing, translation, and RNA transport. DDX3X plays a critical role in the regulation of gene expression and is essential for proper neurodevelopment.
Mutations in DDX3X can disrupt its RNA helicase activity, leading to altered RNA processing and gene expression. These disruptions can impair neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are crucial for cognitive function and behavioral regulation.
Individuals with DDX3X mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with DDX3X mutations may include intellectual disability, developmental delays, hypotonia, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include motor deficits, seizures, and other neurological symptoms.

The DNMT3A gene (DNA Methyltransferase 3 Alpha) plays a crucial role in epigenetic regulation by encoding an enzyme responsible for de novo DNA methylation. This process involves adding methyl groups to DNA, which can regulate gene expression by altering chromatin structure and accessibility.
Mutations in DNMT3A can disrupt its methyltransferase activity, leading to abnormal DNA methylation patterns and altered gene expression. These disruptions can significantly impact neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are essential for cognitive function and behavioral regulation.
Individuals with DNMT3A mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with DNMT3A mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include growth abnormalities, distinctive facial features, and hematological anomalies.

The DSCAM gene (Down Syndrome Cell Adhesion Molecule) plays a critical role in neurodevelopment, particularly in the processes of axon guidance, dendrite branching, and synaptic formation. DSCAM encodes a protein that is involved in cell adhesion and signaling, which are essential for the proper wiring of the nervous system.
Mutations in DSCAM can disrupt these processes, leading to abnormalities in neuronal connectivity and synaptic formation. These disruptions can significantly affect neurodevelopmental processes and contribute to various neurological disorders.
Individuals with DSCAM mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with DSCAM mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include motor deficits and other neurological symptoms.

The GRIN2A gene (Glutamate Ionotropic Receptor NMDA Type Subunit 2A) encodes a critical subunit of the NMDA receptor, which is essential for synaptic plasticity, learning, and memory. The NMDA receptor is a key player in excitatory neurotransmission and plays a vital role in brain development and function.
Mutations in GRIN2A can disrupt the normal function of NMDA receptors, leading to altered synaptic transmission and impaired neuronal connectivity. These disruptions can significantly impact neurodevelopmental processes, contributing to various neurological disorders.
Individuals with GRIN2A mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with GRIN2A mutations may include intellectual disability, developmental delays, epilepsy, impaired social interactions, communication difficulties, and repetitive behaviors. The severity of symptoms can vary widely depending on the nature of the mutation and its impact on NMDA receptor function.

The KATNAL2 gene (Katanin Catalytic Subunit A1-Like 2) is involved in the regulation of microtubule dynamics. KATNAL2 encodes a protein that is crucial for microtubule severing, which is essential for various cellular processes, including cell division, intracellular transport, and particularly for the development and maintenance of neuronal architecture.
Mutations in KATNAL2 can disrupt microtubule dynamics, leading to impaired neuronal function and altered neurodevelopment. These disruptions can significantly impact processes such as neuronal differentiation, migration, and synapse formation, which are critical for cognitive function and behavioral regulation.
Individuals with KATNAL2 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with KATNAL2 mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include motor deficits and other neurological symptoms.

The KDM5B gene (Lysine Demethylase 5B), also known as JARID1B, encodes a histone demethylase enzyme that plays a crucial role in the regulation of gene expression through epigenetic mechanisms. KDM5B specifically demethylates tri- and di-methylated lysine 4 on histone H3 (H3K4me3/H3K4me2), marks associated with active transcription.
Mutations in KDM5B can disrupt its demethylase activity, leading to abnormal gene expression patterns and altered chromatin structure. These disruptions can significantly affect neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are essential for cognitive function and behavioral regulation.
Individuals with KDM5B mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with KDM5B mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include growth abnormalities and other congenital anomalies.

The KMT2C gene (Lysine Methyltransferase 2C), also known as MLL3, encodes a protein that is part of the histone methyltransferase family. KMT2C plays a critical role in the regulation of gene expression through the methylation of histone H3 at lysine 4 (H3K4), a modification associated with active transcription. This gene is crucial for proper chromatin organization and the regulation of various genes involved in neurodevelopment.
Mutations in KMT2C can disrupt its methyltransferase activity, leading to abnormal gene expression patterns and altered chromatin structure. These disruptions can impair neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are vital for cognitive function and behavioral regulation.
Individuals with KMT2C mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with KMT2C mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include distinctive facial features, growth abnormalities, and other congenital anomalies.

The KMT5B gene (Lysine Methyltransferase 5B), also known as SUV420H1, encodes an enzyme responsible for the methylation of histone H4 at lysine 20 (H4K20). This specific methylation is important for the regulation of chromatin structure and gene expression, playing a critical role in various cellular processes, including DNA repair, replication, and neurodevelopment.
Mutations in KMT5B can disrupt its methyltransferase activity, leading to abnormal chromatin structure and altered gene expression. These disruptions can significantly impact neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are essential for cognitive function and behavioral regulation.
Individuals with KMT5B mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with KMT5B mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include motor deficits, seizures, and other neurological symptoms.

The PACS1 gene (Phosphofurin Acidic Cluster Sorting Protein 1) encodes a protein involved in the sorting and trafficking of membrane proteins within cells. PACS1 plays a critical role in maintaining cellular homeostasis and proper protein localization, which is essential for various cellular functions, including neurodevelopment.
Mutations in PACS1 can disrupt its role in protein sorting and trafficking, leading to abnormal protein localization and impaired cellular function. These disruptions can significantly affect neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are crucial for cognitive function and behavioral regulation.
Individuals with PACS1 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with PACS1 mutations may include intellectual disability, developmental delays, distinctive facial features, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include motor deficits and other congenital anomalies.

The PTCHD1 gene (Patched Domain Containing 1) encodes a protein that is believed to be involved in the Hedgehog signaling pathway, which is critical for various developmental processes, including the regulation of cell growth and differentiation. The precise role of PTCHD1 in neurodevelopment is still being elucidated, but it is thought to be important for proper neuronal function and development.
Mutations in PTCHD1 can disrupt its function, leading to alterations in the Hedgehog signaling pathway and other related processes. These disruptions can significantly impact neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are essential for cognitive function and behavioral regulation.
Individuals with PTCHD1 mutations often exhibit neurodevelopmental disorders, including Autism Spectrum Disorder (ASD). Clinical features associated with PTCHD1 mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include attention-deficit/hyperactivity disorder (ADHD) and other neurological symptoms.

The SETBP1 gene (SET Binding Protein 1) encodes a protein that interacts with the SET nuclear oncogene and plays a role in transcriptional regulation. SETBP1 is involved in various cellular processes, including the regulation of cell cycle progression, gene expression, and chromatin organization, which are critical for neurodevelopment.
Mutations in SETBP1 can disrupt its regulatory functions, leading to abnormal gene expression and altered cellular processes. These disruptions can significantly impact neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are essential for cognitive function and behavioral regulation.
Individuals with SETBP1 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with SETBP1 mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include distinctive facial features, motor deficits, and other congenital anomalies.

The SETD5 gene (SET Domain Containing 5) encodes a protein that is involved in chromatin modification and regulation of gene expression. SETD5 is part of the family of histone methyltransferases, which modify histones to influence chromatin structure and gene transcription, playing a crucial role in neurodevelopment.
Mutations in SETD5 can disrupt its function, leading to aberrant gene expression and altered chromatin structure. These disruptions can significantly impair neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are essential for cognitive function and behavioral regulation.
Individuals with SETD5 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with SETD5 mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include distinctive facial features, congenital heart defects, and other developmental abnormalities.

The STXBP1 gene (Syntaxin Binding Protein 1) encodes a protein that is crucial for the regulation of synaptic vesicle release, which is essential for neurotransmission. The STXBP1 protein interacts with syntaxins, facilitating the fusion of synaptic vesicles with the presynaptic membrane to release neurotransmitters into the synaptic cleft.
Mutations in STXBP1 can disrupt this critical process, leading to impaired synaptic transmission and altered neuronal communication. These disruptions can significantly impact neurodevelopmental processes such as neuronal differentiation, migration, and synaptic plasticity, which are essential for cognitive function and behavioral regulation.
Individuals with STXBP1 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with STXBP1 mutations may include intellectual disability, developmental delays, epilepsy, impaired social interactions, communication difficulties, and repetitive behaviors. The severity of symptoms can vary widely depending on the nature of the mutation and its impact on synaptic function.

The TBR1 gene (T-box Brain 1) encodes a transcription factor that plays a critical role in brain development, particularly in the development of the cerebral cortex. TBR1 is involved in the regulation of gene expression during neuronal differentiation, migration, and the formation of cortical layers.
Mutations in TBR1 can disrupt its function, leading to abnormal gene expression and altered neuronal development. These disruptions can significantly impact neurodevelopmental processes, resulting in impaired cortical development and synaptic formation, which are essential for cognitive function and behavioral regulation.
Individuals with TBR1 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with TBR1 mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include motor deficits and other neurological symptoms.

The ARHGEF9 gene (Rho Guanine Nucleotide Exchange Factor 9) encodes a protein known as collybistin, which plays a critical role in the regulation of synaptic function. Collybistin is involved in the formation and maintenance of inhibitory synapses by facilitating the clustering of gephyrin and GABA(A) receptors at postsynaptic sites. Mutations in ARHGEF9 can disrupt the function of collybistin, leading to impaired synaptic formation and altered inhibitory neurotransmission. These disruptions can significantly impact neurodevelopmental processes, such as neuronal connectivity and synaptic plasticity, which are essential for cognitive function and behavioral regulation. Individuals with ARHGEF9 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with ARHGEF9 mutations may include intellectual disability, developmental delays, epilepsy, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include anxiety, mood disorders, and other neurological symptoms.

The HNRNPU gene (Heterogeneous Nuclear Ribonucleoprotein U) encodes a protein that is part of the heterogeneous nuclear ribonucleoprotein (hnRNP) complex, which is integral to various aspects of RNA metabolism, including transcription, splicing, and nuclear export. HNRNPU is particularly critical for maintaining the structural integrity of chromatin and the regulation of gene expression during neurodevelopment.
Mutations in HNRNPU can disrupt its function, leading to aberrant RNA processing and transcriptional regulation. These disruptions can significantly impact neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are crucial for proper cognitive function and behavioral regulation.
Individuals with HNRNPU mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with HNRNPU mutations may include severe intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include epilepsy, motor coordination deficits, and other neurological abnormalities.

The PPP2R5B gene encodes a regulatory subunit of protein phosphatase 2A (PP2A), a major serine/threonine phosphatase that plays a crucial role in regulating various cellular processes, including cell growth, division, and signal transduction. PP2A is essential for proper neurodevelopment and brain function. The PPP2R1A gene encodes the alpha isoform of the A subunit of PP2A. The A subunit serves as a scaffold, coordinating the assembly of the catalytic subunit and the regulatory subunits of PP2A, thereby modulating its activity.
Mutations in PPP2R5B or PPP2R1A can disrupt the function of PP2A, leading to aberrant cellular signaling and altered regulation of key pathways involved in neurodevelopment. These disruptions can impair processes such as neuronal differentiation, migration, and synaptic plasticity, which are vital for cognitive function and behavioral regulation.
Individuals with PPP2R5B and PPP2R1A mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with PPP2R5B mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include motor deficits, seizures, and other neurological symptoms.

The SLC6A1 gene (Solute Carrier Family 6 Member 1) encodes the GABA (gamma-aminobutyric acid) transporter 1 (GAT-1), which is responsible for the reuptake of GABA from the synaptic cleft back into neurons. GABA is the primary inhibitory neurotransmitter in the central nervous system, and its regulation is crucial for maintaining neuronal excitability and preventing excessive neuronal firing.
Mutations in SLC6A1 can disrupt the function of GAT-1, leading to impaired GABA reuptake and altered inhibitory neurotransmission. These disruptions can significantly impact neurodevelopmental processes, such as neuronal differentiation, migration, and synaptic formation, which are essential for cognitive function and behavioral regulation.
Individuals with SLC6A1 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with SLC6A1 mutations may include intellectual disability, developmental delays, epilepsy, impaired social interactions, communication difficulties, and repetitive behaviors. The severity of symptoms can vary widely depending on the nature of the mutation and its impact on GABAergic signaling.

The PACS2 gene (Phosphofurin Acidic Cluster Sorting Protein 2) encodes a multifunctional protein involved in intracellular protein trafficking, apoptosis, and mitochondrial dynamics. PACS2 plays a critical role in the maintenance of cellular homeostasis by regulating the transport of proteins between the endoplasmic reticulum, Golgi apparatus, and mitochondria.
Mutations in PACS2 can disrupt these critical processes, leading to impaired cellular function and altered signaling pathways. These disruptions can significantly impact neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are essential for cognitive function and behavioral regulation.
Individuals with PACS2 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with PACS2 mutations may include intellectual disability, developmental delays, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include motor deficits, seizures, and other neurological symptoms.

The MAOA gene encodes the enzyme monoamine oxidase A, which is involved in the breakdown of neurotransmitters such as serotonin, norepinephrine, and dopamine. This enzyme is crucial for the regulation of mood, arousal, and emotions by controlling the levels of these neurotransmitters in the brain. The MAOB gene encodes the enzyme monoamine oxidase B, which is also involved in the breakdown of neurotransmitters, particularly phenylethylamine and certain trace amines. Like MAOA, MAOB plays a crucial role in regulating neurotransmitter levels in the brain and maintaining neural function.
Mutations in the MAOA and MAOB genes can disrupt enzymatic activity, leading to abnormal levels of neurotransmitters. These disruptions can significantly impact neurodevelopmental processes, such as neuronal differentiation, migration, and synaptic plasticity, which are essential for cognitive function and behavioral regulation.
Individuals with MAOA and MAOB mutations may exhibit a variety of neurodevelopmental and behavioral disorders, including autism spectrum disorder. Clinical features associated with MAOA and MAOB mutations may include intellectual disability, developmental delays, aggressive behavior, impaired social interactions, communication difficulties, and repetitive behaviors. Additional features may include mood disorders and other behavioral abnormalities.

The HNRNPC, HNRNPD, HNRNPK, HNRNPR, and HNRNPUL2 genes encode proteins that are part of the heterogeneous nuclear ribonucleoproteins (hnRNPs) family. These proteins play crucial roles in various aspects of RNA metabolism, including transcription, splicing, transport, stability, and translation. They are essential for maintaining the integrity of RNA processing and gene expression regulation.
Mutations in these hnRNP genes can disrupt RNA processing and lead to altered gene expression. The precise functions of each hnRNP protein vary, but collectively they ensure the proper maturation and function of mRNA, which is critical for neurodevelopment.
Disruptions in these hnRNP genes can significantly impact neurodevelopmental processes, such as neuronal differentiation, migration, and synaptic formation. These processes are crucial for proper cognitive function and behavioral regulation. Consequently, mutations in these genes are often associated with neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with mutations in these hnRNP genes may include: intellectual disability, developmental delays, impaired social interactions, communication difficulties, repetitive behaviors, additional neurological symptoms such as seizures and motor deficits.

The TCF7L2 gene (Transcription Factor 7 Like 2) encodes a transcription factor that plays a crucial role in the Wnt signaling pathway, which is essential for various developmental processes, including cell proliferation, differentiation, and apoptosis. TCF7L2 is particularly important for neurodevelopment, as it regulates the expression of genes involved in the formation and maintenance of neural structures.
Mutations in TCF7L2 can disrupt the Wnt signaling pathway, leading to altered transcriptional regulation of target genes. These disruptions can significantly impact neurodevelopmental processes such as neuronal differentiation, migration, and synaptic plasticity, which are essential for cognitive function and behavioral regulation.
Individuals with TCF7L2 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with TCF7L2 mutations may include: intellectual disability, developmental delays, impaired social interactions, communication difficulties, repetitive behaviors, additional features such as motor deficits and other neurological symptoms.

The HECW2 gene (HECT, C2, and WW Domain Containing E3 Ubiquitin Protein Ligase 2) encodes an E3 ubiquitin-protein ligase, which is involved in the ubiquitination process. This process tags proteins for degradation by the proteasome, a critical mechanism for maintaining cellular homeostasis by regulating protein turnover and function. HECW2 plays a significant role in various cellular processes, including cell signaling, apoptosis, and neurodevelopment.
Mutations in HECW2 can disrupt its function, leading to abnormal protein ubiquitination and degradation. These disruptions can significantly impact neurodevelopmental processes such as neuronal differentiation, migration, and synaptic formation, which are essential for proper brain function and cognitive development.
Individuals with HECW2 mutations often exhibit neurodevelopmental disorders, including autism spectrum disorder. Clinical features associated with HECW2 mutations may include: intellectual disability; developmental delays; impaired social interactions; communication difficulties; repetitive behaviors; additional neurological symptoms such as seizures, motor deficits, and distinctive facial features.